| Literature DB >> 18955226 |
Andreas Daugsch1, Cleber S Moraes, Patricia Fort, Yong K Park.
Abstract
Propolis contains resinous substances collected by honey bees from various plant sources and has been used as a traditional folk medicine since ca 300 BC. Nowadays, the use of evidence-based complementary and alternative medicine (CAM) is increasing rapidly and so is the use of propolis in order to treat or support the treatment of various diseases. Much attention has been focused on propolis from Populus sp. (Salicaceae) and Baccharis dracunculifolia (Asteracea), but scientific information about the numerous other types of propolis is still sparse. We gathered six samples of red propolis in five states of Northeastern Brazil. The beehives were located near woody perennial shrubs along the sea and river shores. The bees were observed to collect red resinous exudates on Dalbergia ecastophyllum (L) Taub. (Leguminosae) to make propolis. The flavonoids of propolis and red resinous exudates were investigated using reversed-phase high-performance liquid chromatography and reversed-phase high-performance thin-layer chromatography. We conclude that the botanical origin of the reddish propolis is D. ecastophyllum. In areas where this source (D. ecastophyllum) was scarce or missing, bees were collecting resinous material from other plants. Propolis, which contained the chemical constituents from the main botanical origin, showed higher antimicrobial activity.Entities:
Year: 2007 PMID: 18955226 PMCID: PMC2586321 DOI: 10.1093/ecam/nem057
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1.Collection of propolis from reddish resinous exudates of D. ecastophyllum by africanized Apis mellifera. (A) Secrete reddish exudates from a hole in a branch of the tree. (B) Bee is collecting the reddish exudates. (C) The collected exudates passed to the hind leg to make propolis.
Figure 2.RPHPTLC of the ethanolic extracts of propolis and reddish exudates from D. ecastophyllum. 3 µL of respective solution described in method were applied. (A) Ethanolic extracts of propolis; (B) Ethanolic extracts of reddish exudates from sample of Fig. 1A; and (C) Ethanolic extracts of reddish exudates from sample of Fig. 1B.
Figure 3.RPHPLC of ethanolic extracts of propolis and reddish resinous exudates from D. ecastophyllum. Respective numbers of peak represent chemical constituents that were described in Table 1.
Flavonoids and other chemical constituents of propolis and D. ecastophyllum
| Propolis | ||||
|---|---|---|---|---|
| Peak | Retention time (min) | Compound | Content (mg/g) | Content (mg/g) |
| 1 | 13.42 | Rutin | 0.7 | 1.3 |
| 2 | 16.99 | Liquiritigenin | 1.8 | 7.1 |
| 3 | 20.63 | Daidzein | 0.3 | 4.3 |
| 4 | 22.35 | Pinobanksin | 1.7 | 6.0 |
| 5 | 23.84 | UV λ 251, 292 nm | + | + |
| 6 | 24.59 | Quercetin | 0.5 | 1.9 |
| 7 | 28.40 | Luteolin | 1.2 | 2.1 |
| 8 | 30.46 | UV λ 241, 272, 282 nm | + | + |
| 9 | 32.15 | Dalbergin | 0.4 | 0.9 |
| 10 | 34.62 | Isoliquiritigenin | 4.8 | 12.1 |
| 11 | 36.97 | Formononetin | 10.2 | 19.5 |
| 12 | 39.28 | UV λ 235, 263 nm | + | + |
| 13 | 40.08 | Pinocembrin | 3.3 | 7.1 |
| 14 | 42.30 | Pinobanksin-3-acetate | 1.7 | 2.6 |
| 15 | 46.45 | Biochanin A | 0.5 | 1.5 |
| 16 | 55.96 | UV λ 238, 260, 269 nm | + | + |
| 17 | 60.53 | UV λ 233, 249, 329 nm | + | + |
| 18 | 63.43 | UV λ 233, 256 nm | + | + |
†Quantity of constituents in mg/g of propolis and D. ecastophyllum.
Symbols: ‘+’ means present, but not quantified.
‡Unidentified constituents represent only UV spectral absorption maximum.
Figure 4.RPHPLC and RPHPTLC of the ethanolic extracts of 6 samples of propolis (one sample from one beehive) collected in same regions.
Flavonoids and other chemical constituents of red propolis
| Propolis2 | Propolis3 | Propolis4 | Propolis5 | |||
|---|---|---|---|---|---|---|
| Peak | Retention time (min) | Compound | Content (mg/g) | Content (mg/g) | Content (mg/g) | Content (mg/g) |
| 1 | 13.42 | Rutin | 0.7 | 1.1 | 0.9 | 0.6 |
| 2 | 16.99 | Liquiritigenin | 1.8 | 5.7 | 5.0 | 2.2 |
| 3 | 20.63 | Daidzein | 0.3 | 0.6 | 0.5 | 0.2 |
| 4 | 22.35 | Pinobanksin | 1.7 | 5.7 | 4.9 | 3.3 |
| 5 | 23.84 | UV λ 251, 292 nm | + | + | + | + |
| 6 | 24.59 | Quercetin | 0.5 | 3.0 | 4.5 | 2.6 |
| 7 | 28.40 | Luteolin | 1.2 | 2.5 | 2.4 | 1.5 |
| 8 | 30.46 | UV λ 241, 272, 282 nm | + | + | + | + |
| 9 | 32.15 | Dalbergin | 0.4 | 2.4 | 2.5 | 1.4 |
| 10 | 34.62 | Isoliquiritigenin | 4.8 | 9.9 | 8.3 | 5.5 |
| 11 | 36.97 | Formononetin | 10.2 | 10.7 | 10.9 | 10.5 |
| 12 | 39.28 | UV λ 235, 263 nm | + | + | + | + |
| 13 | 40.08 | Pinocembrin | 3.3 | 9.8 | 8.3 | 7.3 |
| 14 | 42.30 | Pinobanksin-3-acetate | 1.7 | 3.6 | 2.4 | 2.3 |
| 15 | 46.45 | Biochanin A | 0.5 | 2.1 | 1.7 | 0.4 |
| 16 | 55.96 | UV λ 238, 260, 269 nm | + | + | + | + |
| 17 | 60.53 | UV λ 233, 249, 329 nm | + | + | + | + |
| 18 | 63.43 | UV λ 233, 256 nm | + | + | + | + |
†Quantity of constituents in mg/g of propolis and D. ecastophyllum.
Symbols: ‘+’ means present, but not quantified.
‡Unidentified constituents represent only UV spectral absorption maximum.
Figure 5.Growth inhibition of Staphylococcus aureus ATCC 25923 by extracts of propolis. 10 µL of respective solution described in method were applied to the disks.